Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro, JJ. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro, JJ
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib attributed stroke rate by age
    The percentage of strokes attributable to atrial fibrillation increases from 1.5% at ages 50 to 59, to 23.5% at ages 80 to 89.  
  • Atrial fibrillation on death certificates
    In 2008, atrial fibrillation was mentioned on 99,294 death certificates in the U.S. and was the underlying cause of death in 15,383.  
  • Hospitalization costs for patients with nonrecurrent ischemic stroke
    The cost of hospitalization for patients with nonrecurrent ischemic stroke is $4,991 more in patients with atrial fibrillation, than in patients without the disease.        
  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.  
  • Average age of AFib patients
    The mean age for atrial fibrillation is 66.8 years in men and 74.6 years in women.